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introduction
Due to the favourable depth dose characteristics of 
protons when compared to conventional photon therapy, 
the number of proton centres is growing globally. Most of 
the new centres are built for proton pencil beam scanning 
(PBS), as its intrinsic dose painting potential1 can be used 
to maximise the dose to the tumour while sparing nearby 
organs at risk.
To ensure good treatment outcome however, accurate dose 
calculations to predict and plan the delivered dose are crit-
ical. At treatment sites with complex inhomogeneities, there 
is an uncertainty in the proton range predicted by analyt-
ical algorithms, and Monte Carlo (MC) particle transport 
simulations can substantially improve the accuracy of the 
predicted doses.2 Therefore, many centres are now using 
MC calculation algorithms for proton PBS (e.g. Yepes et al, 
Tommasino et al, Widesott et al3–5).
Multiple MC codes are available for medical physics appli-
cations, as for example Geant46 (and Geant4 wrappers 
GATE,7 TOPAS8 and GAMOS9), PHITS,10 MCNP11 and 
FLUKA.12 To investigate the differences between MC algo-
rithms in a clinical setting, in13 Geant4 and a MCNPX- 
based MC calculation algorithms were compared. Since 
these two models had been set up for two different proton 
therapy treatment heads however, only monoenergetic 
beams, and not patient dose distributions were compared 
in the patient CT. For Geant4 applications, physics settings 
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objective: Monte Carlo (MC) simulations substantially 
improve the accuracy of predicted doses. This study 
aims to determine and quantify the uncertainties of 
setting up such a MC system.
Methods: Doses simulated with two Geant4- based MC 
calculation codes, but independently tuned to the same 
beam data, have been compared. Different methods of 
MC modelling of a pre- absorber have been employed, 
either modifying the beam source parameters (descrip-
tive) or adding the pre- absorber as a physical compo-
nent (physical).
results: After the independent beam modelling of both 
systems in water (resulting in excellent range agree-
ment) range differences of up to 3.6/4.8 mm (1.5% of 
total range) in bone/brain- like tissues were found, which 
resulted from the use of different mean water ionisa-
tion potentials during the energy tuning process. When 
repeating using a common definition of water, ranges in 
bone/brain agreed within 0.1 mm and gamma- analysis 
(global 1%,1mm) showed excellent agreement (>93%) 
for all patient fields. However, due to a lack of modelling 
of proton fluence loss in the descriptive pre- absorber, 
differences of 7% in absolute dose between the pre- 
absorber definitions were found.
conclusion: This study quantifies the influence of using 
different water ionisation potentials during the MC beam 
modelling process. Furthermore, when using a descrip-
tive pre- absorber model, additional Faraday cup or ioni-
sation chamber measurements with pre- absorber are 
necessary.
advances in knowledge: This is the first study quanti-
fying the uncertainties caused by the MC beam model-
ling process for proton pencil beam scanning, and a 
more detailed beam modelling process for MC simula-
tions is proposed to minimise the influence of critical 
parameters.
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water and in PMMA,14 as well as in water and for a Faraday 
cup model,15 with both studies resulting in optimised physics 
and parameter settings. Additionally, the influence of ionisation 
values on proton ranges has been evaluated for monoenergetic 
proton beams in water/tissue cylinders.16
Multipurpose MC codes such as Geant4, however, are highly 
flexible, and are not trivial to set- up and configure for non- 
expert users in the clinical environment. For ease of configu-
ration of Geant46 for medical physics applications therefore, 
two toolkits are available—GATE (Geant4 Application for 
Tomographic Emission7) and TOPAS (TOol for PArticle Simu-
lations8). Both allow the user to define complex simulation 
setups in text based parameter files, and MC calculations for 
proton PBS using these toolkits have been set up at multiple 
institutes.17–20 Indeed, with steadily increasing numbers of 
proton treatment centres, more and more will set up institute 
specific MC calculations. As such, GATE and TOPAS facil-
itate the use of Geant4 by users (such as Medical Physicists) 
without requiring them to have developer level experience of 
Geant4. Even using such toolkits however, MC calculations for 
proton PBS are not yet off- the- shelf tools, and there is a lack of 
comparison of MC descriptions of proton PBnoS Gantries for 
clinical proton dose calculations which take into account the 
whole setup and beam modelling process.
In this study, at two different institutions, similar MC calcula-
tion systems, one based on GATE and one TOPAS, have been 
independently developed and tuned using the same measured 
data from a proton PBS Gantry. In this collaborative study, dose 
distributions calculated in both systems were then compared 
in simple geometric setups and in clinical patient calculations. 
This study aimed to identify how choices during the configura-
tion of MC simulation systems influence and potentially bias the 
MC simulation results and how this can be prevented. It there-
fore highlights potential pitfalls during the MC beam modelling 
process and concludes with an updated beam modelling proce-
dure to prevent these.
The study is structured as follows: first, the setup of the MC 
systems is presented. Next, the system validation and the 
comparison of dose results in simple geometric and clinical 
patient cases are shown. Based on these results, critical factors 
when setting up a MC system for proton PBS are identified 
and the dose differences due to the different beam modelling 
discussed. Finally, an updated beam modelling procedure is 
introduced to mitigate these factors and lead to more consistent 
MC results.
Methods and Materials
Setting up a PBS MC system
To set up a PBS MC system, the underlying MC code needs to 
be chosen and physics models defined. Additionally, institute- 
specific geometry and beam models need to be implemented. 
In the following, the beam modelling process is explained (see 
“Beam modelling for a PBS MC system”) and the two setups are 
explained (“PSI and The Christie MC Systems”) and compared in 
more detail (“System comparison”).
Beam modelling for a PBS MC system
For passive scattering proton therapy, a detailed model of the 
treatment head needs to be included in the MC simulation (see, 
e.g. Verburg et al21). In contrast however, for PBS proton therapy, 
even though there is a low- dose spray due to interactions within 
the beam line and Gantry,19,22 MC simulations can be started at a 
defined point before the patient, and not all hardware needs to be 
explicitly modelled.17–21 At this starting point, each pencil beam 
is described by its number of protons, energy, energy spread, 
and initial optical phase space (beam size, angular spread and 
correlation). In this study, proton numbers per monitor units 
have been defined based on Faraday cup measurements (see 
Winterhalter et al17 for more details on the absolute dose vali-
dation of this approach), nominal energy and energy spreads 
have been iteratively adjusted to reproduce depth–dose curves 
in water and the initial optical phase space characterised by 
subtracting the air scattering contribution from the measured 
beam data (see Grevillot et al20 for more detail). Additionally, to 
deliver pencil beams with energies below the lowest range that 
can be transported through the beam line (70 MeV for the PSI 
Gantry 2), a pre- absorber (range shifter) is typically required. 
This pre- absorber can either be modelled as a physical compo-
nent, whereby all protons are tracked through the pre- absorber 
as part of the MC simulations,17,19,23 or as a descriptive compo-
nent by adjusting the beam energy, energy spread and phase 
space after the pre- absorber accordingly.18 These data are then 
used to perform a pre- absorber specific beam modelling of the 
MC.
In summary, based on previous literature, the beam modelling 
process contains the following steps:
(1) Without pre- absorber:
•	 Characterise the beam optics (initial 
phase space: beam size, angular spread 
and correlation) of pencil beams in air 
(for each nozzle extension).
•	 Tune energy and energy spread to re-
produce measured depth–dose curves 
in water.
(2) With a physical pre- absorber
•	 Tune material properties of the pre- 
absorber (e.g. density within manufac-
turer specifications) to match depth–
dose curves in water measured with 
the pre- absorber
OR With a descriptive pre- absorber
•	 Characterise initial phase space of 
pencil beams in air (for each nozzle 
extension) to match measurements 
of beam sizes in air with the pre- 
absorber.
•	 Tune energy and energy spread to re-
produce depth–dose curves in water 
measured with the pre- absorber.
(3) Convert CT voxels to material and density.
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It is worth mentioning that the PSI Gantry 2 has a telescopic 
nozzle, which moves the pre- absorber and all nozzle monitors in 
relation to the isocentre.24 The phase space parametrisation (for 
the descriptive pre- absorber and also without pre- absorber due 
to the changing positions of nozzle monitors), therefore needs to 
be repeated for each nozzle extension.
PSI and The Christie MC Systems
Two MC models, tuned to the same PSI Gantry 2 commissioning 
measured beam data, have been independently developed at 
two different institutes (PSI and The Christie). These beam data 
consisted of integral depth–dose curves measured with a Bragg 
peak chamber (diameter 8 cm) and spot sizes in air measured 
with a scintillating screen.
Both systems are based on the Geant4 10.02 .p01 MC code, with 
the PSI system being modelled with the TOPAS 3.0 .p1 and The 
Christie system with the GATE 7.2 toolkit. Physics have been 
defined as the TOPAS default physics list8,15 (consisting of the 
G4EMStandardPhysics_option4, HadronPhysicsQGSP_BIC_
HP, G4DecayPhysics, G4IonBinaryCascadePhysics, G4Hadro-
nElasticPhysicsHP and G4StoppingPhysics Geant4 classes) in 
the PSI system and the QGSP_BIC Geant4 reference list (chosen 
based on25 and26) in The Christie model. Range cuts of 0.05 mm 
(PSI system) and 0.1 mm (The Christie system) have been used. 
No variance reduction techniques were applied.
For the PSI model, simulations started at the upstream side of the 
pre- absorber with the nozzle fully retracted (47.8 cm upstream 
of isocenter) and for The Christie at the primary dose monitor 
(74.1 cm upstream of isocenter). In addition, the pre- absorber 
has been modelled as a physical component at PSI and as a 
descriptive component (as used in Fracchiolla et al,18 see “Setting 
up a PBS MC system” above) by The Christie. Both systems 
apply the same number of protons per pencil beam and the two 
beam models have been tuned independently (Beam modelling 
for a PBS MC system). Supplementary Table 1 summarises the 
settings of both systems.
Finally, for both systems, the same CT calibration has been 
applied, derived using the calibration described by Schneider et 
al.27 In this process, the CT scanner is first characterised by scan-
ning a set of materials of known composition and density, and for 
which the proton stopping power can be theoretically calculated. 
The scanner response is then characterised by parametrising the 
relationship between the theoretical stopping powers and the 
measured Hounsfield unit (HU) values for each material.28 Using 
this parametrisation, predicted HU values are then calculated for 
a set of 71 reference human tissues. This provides a table which 
acts as a calibration for the CT scanner, and which can be applied 
to any patient CT image to provide a mapping between a voxel's 
measured HU value and a corresponding reference tissue defini-
tion (in terms of material composition and density).
System comparison
Water and air
For three example pencil beams without pre- absorber (energies 
71, 163 and 229 MeV) and three with pre- absorber (86, 163 and 
229 MeV), simulations in air and water have been performed, 
using the same geometry and scoring setup for both MC models. 
Doses were scored and compared in water/air cuboids with 10 
x 10 cm cross- sections and 36 cm (water)/50 cm (air) depths. 
Scoring dimensions were 0.5 mm (in depth) x 1 x 1mm and 107 
protons were simulated for each pencil beam, and beam sizes (σ 
of the Gaussian beam) in air, depth–dose curves and absolute 
doses scored in the whole water cuboid compared.
The initial phase space and the position of the pre- absorber 
corresponds to a fully extracted nozzle, and, in accordance with 
the commissioning measurements, the surface of the water 
phantom has been positioned at the isocenter/13.1 cm upstream 
of isocenter (without/with pre- absorber). With pre- absorber, this 
leads to an air- gap of 6.2 cm between the downstream surface of 
the pre- absorber and the upstream surface of the water phantom.
Material blocks
For three pencil beams (71 MeV (no pre- absorber)/86 MeV 
(with pre- absorber), 163 MeV, 229 MeV), simulated doses for 
both MC setups have been compared in brain and in bone like 
cuboids with the same physical and scoring dimensions as the 
water cuboid. Brain (density = 1.04 g/cm3) and bone (density = 
1.42 g/cm3) are defined according to ICRU_4629 (Table A2).
Patient CT
Dose distributions have also been compared in a patient CT 
data (CT voxel dimensions 1.7 ⨯ 1.7 ⨯ 2.0 mm; dose grid voxel 
dimensions 2.0 ⨯ 2.0 ⨯ 2.0 mm) for a three field SFUD (single 
field uniform dose) plan without pre- absorber and a four- field 
IMPT (intensity modulated proton therapy) plan with pre- 
absorber (CT voxel dimensions 1.2 ⨯ 1.2 ⨯ 2.0 mm; dose grid 
voxel dimensions 2.0 ⨯ 2.0 ⨯ 2.0 mm). Proton numbers for each 
spot are based on Faraday cup measurements.17. For all simula-
tions, a sufficiently large number of primary protons have been 
simulated in order to ensure that the statistical uncertainty in 
the calculated dose was acceptably low, such that any observed 
differences within the study were due to the configuration of the 
simulations, rather than due to statistical artefacts. Therefore, 
all fields have been calculated by scaling the number of protons 
per field to 1.7–4.0 × 108 protons per field, providing a statistical 
uncertainty at the 90–100% dose level of ≤0.35% (as calculated in 
the GATE simulations according to Chetty et al30).
Differences are quantitatively analysed by examining dose differ-
ence distributions and by using the global γ analysis,31 in which 
the data simulated with the PSI model is the evaluated, and the 





For simulations in water without the pre- absorber (Figure  1a) 
ranges for both models agreed to within 0.25 mm, which is 
a good agreement taking into account that the beam model-
ling processes have been performed independently, with toler-
ances of 0.1 mm and independent scoring settings. In addition, 
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absolute doses agreed to within 1.01% and beam sizes in air (σ of 
the Gaussian beam) to within 0.34 mm.
Comparison in non-water tissues (material blocks 
and patient CTs)
In contrast, in the simulated material blocks, ranges were found 
to differ by 0.7/2.1/3.6 mm (2.2/1.5/1.5% of total range) for 
energies of 71/163/229 MeV transported through bone and by 
0.9/2.8/4.8 mm (2.2/1.6/1.5% of total range) through brain tissue 
(Figure  1b) with the The Christie system predicting deeper 
ranges than the PSI model.
When comparing clinical dose distributions in the patient CT 
(Figure 2), The The Christie model again predicted higher ranges 
in the patient and, although γ analysis showed relatively good 
agreement for a (2%, 2 mm) criterion (>95% agreement for all 
fields), a significant amount of voxels failed for a stricter (1%, 
1 mm) comparison (≤75% pass rate for all fields).
Further investigation of range discrepancies
Based on these results, the substantial range discrepancies 
found in both material blocks and the patient CT between the 
two systems were further investigated. Consequently, it was 
Figure 2. For a clinical proton field without pre- absorber, doses calculated with the PSI MC algorithm (a), the independently 
developed The Christie model (b) and the dose difference PSI – The Christie on one example slice through the high dose region 
(c) and as a histogram for the whole distribution (d). MC, Monte Carlo.
Figure 1. Depth–dose curves in water (a) and brain (b) without pre- absorber, plotted as step plots. Statistical uncertainty does not 
influence the shape of the curves and resulting range and absolute dose agreement.
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found that, during the independent beam modelling of the two 
systems, the definition of water for the two systems differed. 
Water had not been defined using the HU conversion, but, in 
the PSI system defined using the Geant4 default water descrip-
tion (fractions: H: 0.111894 & O:0.888106, density 1.0 g/cm3, 
I = 78 eV), and in The Christie system using its elemental 
composition (H2O, density 1.0 g/cm3, I = 69 eV calculated 
internally in Geant4). Consequently, the Christie system was 
then re- tuned using the same water definition as the PSI. After 
this re- tuning, ranges between both systems agreed to within 
0.1 mm for water and all material blocks (Figure  1, PSI and 
water matched The Christie system), beam sizes in air agreed 
within 0.33 mm and absolute doses in water within 0.24%. In 
addition, agreement substantially improved for the compar-
ison in the patient CT (Figure 3), with the γ analysis agreement 
at the 1%, 1 mm level increasing to >93% for all fields, and 
most voxels (>97% for all fields) agreeing to within ±2.5% of 
prescription dose (Table 1) for doses > 10% in the patient after 
re- tuning of the Christie system.
Comparison with pre-absorber
Comparison in air/water with pre-absorber
With the pre- absorber (Figure  4), ranges between the water 
matched systems also agree to within 0.25 mm. Addition-
ally, beam sizes are reproduced well downstream of the pre- 
absorber for higher energies, with a slightly higher difference 
of 0.68 mm in air for the lowest energy. Most importantly 
however, absolute doses in water simulated with the descrip-
tive pre- absorber (The Christie system) were found to be 6.9%, 
4.0%. 4.2% higher (86, 163, 229 MeV) than for the physical 
pre- absorber (PSI setup).
Figure 5 shows the lateral beam profiles for the 163 MeV beam in 
water with (a–c) and without pre- absorber (d–f) at the entrance 
of the water phantom (a, d), at 5 cm depth (b, e) and at 10 cm 
depth (c,f) on a logarithmic scale to further investigate the origin 
of these absolute dose differences.
Comparison in non-water tissues with pre-absorber
Ranges in bone and brain agreed to within 0.27 mm after water 
matching. Absolute dose differences however were found to 
be comparable to the water simulations (6.9/3.8/4.0% bone, 
6.9/4.0/4.2% brain). Similarly, although relative doses agree 
well between the two pre- absorber descriptions in the patient 
CT (Figure 6 and Table 1), the absolute doses predicted using 
the descriptive pre- absorber (The Christie system) are also 
7% higher than those predicted when using the physical pre- 
absorber (PSI model).
When, however, a physical instead of a descriptive pre- absorber 
is included in the Christie setup (using the same definitions as in 
the PSI system), relative and absolute doses agree well between 
the two systems with >98% γ analysis agreement at the 1%, 1 mm 
level without any additional scaling (Figure 7 and Table 1).
Figure 3. For a clinical proton field without pre- absorber, doses calculated with the PSI MC algorithm (a), doses calculated with 
the water matched The Christie MC model (b) and the dose difference PSI – Christie on one example slice through the high dose 
region (c) and as a histogram for the whole distribution (d). MC, Monte Carlo.
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discussion
In this study, two MC systems based on the same MC code 
have been independently tuned and compared using iden-
tical proton PBS beam data. It is the first study to quantify 
the precision of such MC setups and to demonstrate potential 
differences resulting from the setup processes alone from the 
perspective of a clinical user. Even though these differences are 
small when compared to other uncertainties, as for example 
patient setup and CT conversion (see Paganetti2 for more 
detail), it is important to note that there is also an uncertainty 
correlated to the setup process of the MC algorithm itself. 
Indeed, as it is impossible to measure the dose in the patient, 
there is no easy way of determining to what extent any MC 
system represents the ground truth in the patient.
During the beam modelling processes performed here, 
different values for the ionisation potential of water were inad-
vertently defined in the two systems. In the PSI system, the 
Geant4 default value for water of 78 eV was used, whereas in 
the independently tuned The Christie model, this was calcu-
lated internally using the Bragg additivity rule,32 leading to an 
ionisation potential of 69 eV. Only after retuning of one system 
to be based on the same ionisation potential of water did both 
simulation algorithms agree well (1%, 1 mm γ agreement >93% 
for all fields).
The authors of Andreo16 have previously demonstrated the 
differences of proton ranges in water for monoenergetic beams 
when varying the ionisation potential of water. Despite this 
however, and even before the re- tuning of the Christie system, 
ranges in water agreed well, since the energy of the pencil 
beams were individually tuned to reproduce measurements in 
water. Consequently, the differences due to the chosen ionisa-
tion potentials were not visible when comparing simulations 
in water and were only revealed when comparing dose distri-
butions in other materials (material blocks or patient CT). In 
fact, if the authors had not done this comparison study, the 
two institutions may have used two MC calculation systems 
predicting substantially different ranges in non- water mate-
rials for the same beam data.
Unfortunately, it is not possible to say which system (or choice 
of ionisation potentials) is more accurate in the patient, as 
direct validation of calculated range in vivo at the resolutions 
required is extremely challenging. Validation measurements 
need therefore to be performed in anthropomorphic and 
Table 1. Dose differences and γ analysis for the comparison of clinical plans between The Christie models and the PSI.model
Water matched systems F0 F1 F2
Voxels within ±2.5% 97.8 % 98.8% 99.9 %
γ analysis: 1%, 1 mm 93.8 % 95.5 % 98.6 %
γ analysis: 2%, 2 mm 99.9 % 99.9 % 100 %
     
Pre- absorber models F0 F1 F2 F3
Scaling 0.926 0.933 0.925 0.927
Voxels within ±2.5% 90.6 % 95.2% 87.6 % 93.6 %
γ analysis: 1%, 1 mm 93.3 % 99.0 % 94.6 % 94.9%
γ analysis: 2%, 2 mm 99.5 % 100 % 99.9 % 99.6%
     
Physical pre- absorber in both systems F0 F1 F2 F3
Voxels within ±2.5% 98.7 % 99.8% 98.8 % 99.0 %
γ analysis: 1%, 1 mm 99.0 % 100 % 99.8 % 98.9 %
γ analysis: 2%, 2 mm 100 % 100 % 100 % 100 %
For the pre- absorber plan, doses predicted by the Christie system have been scaled to account for an absolute dose offset (Scaling factor).
Figure 4. Depth–dose curves in water with pre- absorber, plot-
ted as step plots. Statistical uncertainty does not influence the 
shape of the curves and resulting range and absolute dose 
agreement.
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Figure 5. Lateral beam profiles plotted using a logarithmic scale for the 163 MeV beam in water with (a–c) and without pre- 
absorber (d–f) at the entrance of the water phantom (a, d), at 5 cm depth (b, e) and at 10 cm depth (c,f). Statistical fluctuations 
lead to variations of the individual low dose points, but do not influence the conclusion drawn from this figure.
Figure 6. For a clinical proton field with pre- absorber, doses calculated with the PSI MC algorithm (physical pre- absorber, (a)), 
the water matched Christie MC model (descriptive pre- absorber, (b)) and the dose difference PSI – Christie on one example slice 
(c) and as a histogram for the whole distribution (d). The Christie doses are scaled by 7% to show the relative agreement. MC, 
Monte Carlo.
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heterogeneous phantoms. Even then, such measurements are 
subject to many experimental uncertainties, and often eval-
uated using for example 3%/3 mm γ analysis—which would 
not be sufficient to distinguish these kind of differences. This 
clearly shows that before MC calculation systems are used 
routinely in clinical practice, there is a need for a standard 
validation procedure. This might include an inter comparison 
as has been done in this study, and/or measurements in non- 
water materials.
Indeed, choosing the best ionisation potential for water during 
the tuning process is not necessarily straightforward. On the 
one hand, the current ICRU report recommends I = 78 eV,33 
updated from the previously recommended I = 75 eV.34 On 
the other hand, in both GATE and TOPAS, the ionisation 
potentials used for materials in the patient CT are calculated 
from elemental ionisation potentials using the Bragg addi-
tivity rule. Therefore, it is arguably more consistent to modify/
adjust the ionisation potentials for each element rather than 
to adjust the ionisation potential of water alone. For instance, 
although the ionisation potential of water was changed during 
the beam modelling process of the model, the CT conver-
sion from HU to stopping power was not altered. As such, 
although a consistency in water was achieved between the two 
systems, this may lead to inconsistences for range calculations 
in the patient.
In practice, and based on the derivations of Schneider,27 there are 
two ways to derive the scanner specific HU conversion scheme 
necessary for the MC simulation:
(1) Repeating the calibration process described by Schneider et 
al27 for the institute- specific scanner and scanner settings.
(2) Using the original curve by Schneider et al27 while adjusting 
the densities of the individual materials to match the MC 
calculated stopping powers relative to water to those of the 
institute specific scanner.2
The second approach aims to generate stopping powers for 
MC which are consistent with the treatment planning system. 
This has for example been chosen by Schuemann et al35,36 to 
investigate differences between the analytical and the MC 
simulations. It is however important to note that an ionisation 
potential of water has to be assumed to derive the stopping 
powers relative to water of the institute specific scanner.28 To 
be self- consistent, i.e. achieve the same ranges in the patient 
CT as the treatment planning system, the same I value should 
be used for the tuning process of the MC simulation.
We also observed major differences in results between the 
two MC systems as a result of modelling of the pre- absorber. 
In the literature, pre- absorbers in MC simulations have been 
modelled either as physical components17,19,23 or their effects 
included in the initial beam description.18 When performed 
Figure 7. For a clinical proton field with pre- absorber, doses calculated with the PSI MC algorithm (a), the water matched Chris-
tie MC model (b) when both use a physical pre- absorber and the dose difference PSI – Christie on one example slice (c) and as 
a histogram for the whole distribution (d). In contrast to the descriptive approach, the doses are not scaled and absolute dose 
agreement is shown. MC, Monte Carlo.
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carefully, both are valid approaches, with the descriptive 
approach having the advantage of efficiency for particle 
tracking. However, in our study, when including the pre- 
absorber in the beam optics and using the same number of 
protons, integrated doses (Figure 4) and point to point doses 
in the core (Table 1) were higher when compared to the phys-
ical modelling.
There are two potential reasons for the observed absolute dose 
differences, namely the loss of fluence in the pre- absorber 
and wide angle scattered protons/secondaries originating in 
the pre- absorber. When analysing beam profiles on a loga-
rithmic scale (Figure 5), the difference in the contribution of 
these secondaries on the beam halo (see terminology intro-
duced in Gottschalk et al37) is clearly visible at low depths 
(Figure  5a), an effect not observed without pre- absorber 
(Figure  5d–f). At deeper depths, this difference in the low 
dose halo, however, vanishes (Figure  5b and c), as here the 
secondaries produced in water are more prevalent. The results 
of this study, however, show a systematic absolute dose offset 
over all depths (Figure 4), and the authors therefore conclude 
that the difference in absolute dose is mainly due to the loss 
of fluence in the pre- absorber, and is only partly due to differ-
ences in the modelling of wide angle scattered protons origi-
nating in the pre- absorber, both of which are not taken into 
account correctly in such a descriptive approach. Nevertheless, 
it is interesting to point out the differences in the low dose 
halo between the descriptive and the physical approaches also 
visible in Figure  6, which are not observed when using the 
same pre- absorber approach (Figure 7). This is consistent with 
the work by Grassberger et al,19 who show that not tracking the 
particles through the treatment head results in an underesti-
mation of the dose halo. Investigating the effect of the different 
pre- absorber descriptions on secondaries would be an inter-
esting continuation of this work.
When subsequently including the physical pre- absorber in 
The Christie system, absolute doses agreed well, which vali-
dates that the observed differences are indeed due to the 
pre- absorber modelling approaches and not due to potential 
underlying code differences. This emphasised the importance 
of absolute dose measurements with a pre- absorber when vali-
dating the MC setup, which have shown that absolute doses 
with a physical pre- absorber reproduce measurements with 
only a 1% offset.17 When the pre- absorber cannot be modelled 
as a physical component however, e.g. due to overlap problems 
with the CT or to reduce simulation times and a descriptive 
model is preferred, it is therefore important to take this proton 
loss into account. The descriptive model has, e.g. been success-
fully used by Fracchiolla et al18 to predict absolute doses. 
However, this approach succeeded due to additional measure-
ments that were performed with the pre- absorber to introduce 
an energy dependent scaling factor to modify the fluence of 
each proton pencil beam.
In summary, when following the beam model process as 
described in “Setting up a PBS MC system”, ionisation poten-
tials and the modelling of objects have been shown to be critical 
parameters. This study therefore proposes an extended beam 
modelling procedure (new/altered steps marked in italic):
(1) Choose the water definition, especially the ionisation potential. 
This should be the same as used for the creation of the stopping 
power curve in the TPS.
(2) Without pre- absorber:
•	 Characterise the beam optics (initial 
phase space: beam size, angular spread 
and correlation) of pencil beams in air 
(for each nozzle extension if applica-
ble).
•	 Tune energy and energy spread to re-
produce measured depth dose curves 
in water.
(3) With pre- absorber, physical description
•	 Tune material properties (e.g. density) 
to match depth–dose cuves in water
OR With pre- absorber, optical description.
•	 Characterise initial phase space of 
pencil beams in air (for each nozzle 
extension).
•	 Tune energy and energy spread and 
proton number to reproduce measured 
depth–dose curves in water.
(4) Perform validation procedures, e.g. the intercomparison 
between MC algorithms and/or measurements in non- water 
materials.
(5) For the CT conversion, use the original curve by Schneider et 
al27 while adjusting the densities of the individual materials to 
match the MC calculated stopping powers relative to water to 
those of the institute- specific scanner.
Conclusions
This study highlights some potential uncertainties that can 
occur purely from the process of beam modelling for MC 
systems for proton PBS therapy. As such, new steps in the 
beam modelling process are proposed, to potentially mini-
mise the influence of ionisation potentials and the modelling 
of objects, which have been shown to be critical parameters. 
Standard validation procedures, including an intercomparison 
between different MC algorithms and/or MC- calculated and 
measured dose distributions in non- water materials, should 
be considered when introducing MC calculations in clinical 
practice.
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notes
The TOPAS website states: “Our mission is to make TOPAS into 
a tool that fits comfortably into the hands of every medical phys-
icist.” (url: http://www. topasmc. org, 10th July 2019).
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